v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF COMMON STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Retained Earnings
Balance at beginning of period (in shares) at Dec. 31, 2024   17,887  
Balance at beginning of period at Dec. 31, 2024 $ 445,263 $ 248,202 $ 197,061
Increase (Decrease) in Stockholders' Equity [Roll Forward]      
Net Income 9,479   9,479
Dividend Reinvestment & Common Stock Purchase Plan (in shares)   4  
Dividend Reinvestment & Common Stock Purchase Plan 221 $ 221  
Restricted Stock Award - Net - Employees (in shares)   1  
Restricted Stock Award -Net-Employees 167 $ 167  
Conversion of $7 Preferred Stock to Common Stock (in shares)   2  
Conversion of $7 Preferred Stock to Common Stock 21 $ 21  
Cash Dividends on Common Stock (6,081)   (6,081)
Cash Dividends on Preferred Stock (22)   (22)
Balance at end of period (in shares) at Mar. 31, 2025   17,894  
Balance at end of period at Mar. 31, 2025 449,048 $ 248,611 200,437
Balance at beginning of period (in shares) at Dec. 31, 2024   17,887  
Balance at beginning of period at Dec. 31, 2024 445,263 $ 248,202 197,061
Increase (Decrease) in Stockholders' Equity [Roll Forward]      
Net Income 20,258    
Balance at end of period (in shares) at Jun. 30, 2025   18,016  
Balance at end of period at Jun. 30, 2025 457,783 $ 252,688 205,095
Balance at beginning of period (in shares) at Mar. 31, 2025   17,894  
Balance at beginning of period at Mar. 31, 2025 449,048 $ 248,611 200,437
Increase (Decrease) in Stockholders' Equity [Roll Forward]      
Net Income 10,778   10,778
Dividend Reinvestment & Common Stock Purchase Plan (in shares)   4  
Dividend Reinvestment & Common Stock Purchase Plan 229 $ 229  
Restricted Stock Award - Net - Employees (in shares)   18  
Restricted Stock Award -Net-Employees 47 $ 47  
Restricted Stock Award - Board of Directors (in shares)   6  
Restricted Stock Award - Board of Directors 366 $ 366  
Conversion of $7 Preferred Stock to Common Stock (in shares)   30  
Conversion of $7 Preferred Stock to Common Stock 262 $ 262  
At-The-Market Program Common Stock Issuance (in shares)   64  
At-The-Market Program Common Stock Issuance 3,604 $ 3,604  
Common Stock Issuance Expense (431) $ (431)  
Cash Dividends on Common Stock (6,101)   (6,101)
Cash Dividends on Preferred Stock (19)   (19)
Balance at end of period (in shares) at Jun. 30, 2025   18,016  
Balance at end of period at Jun. 30, 2025 $ 457,783 $ 252,688 205,095
Balance at beginning of period (in shares) at Dec. 31, 2025 18,521 18,521  
Balance at beginning of period at Dec. 31, 2025 $ 494,031 $ 279,148 214,883
Increase (Decrease) in Stockholders' Equity [Roll Forward]      
Net Income 10,605   10,605
Dividend Reinvestment & Common Stock Purchase Plan (in shares)   4  
Dividend Reinvestment & Common Stock Purchase Plan 217 $ 217  
Restricted Stock Award - Net - Employees (in shares)   3  
Restricted Stock Award -Net-Employees 276 $ 276  
At-The-Market Program Common Stock Issuance (in shares)   49  
At-The-Market Program Common Stock Issuance 2,662 $ 2,662  
Common Stock Issuance Expense (60) $ (60)  
Cash Dividends on Common Stock (6,667)   (6,667)
Cash Dividends on Preferred Stock (18)   (18)
Balance at end of period (in shares) at Mar. 31, 2026   18,577  
Balance at end of period at Mar. 31, 2026 $ 501,046 $ 282,243 218,803
Balance at beginning of period (in shares) at Dec. 31, 2025 18,521 18,521  
Balance at beginning of period at Dec. 31, 2025 $ 494,031 $ 279,148 214,883
Increase (Decrease) in Stockholders' Equity [Roll Forward]      
Net Income $ 25,377    
Balance at end of period (in shares) at Jun. 30, 2026 18,843 18,843  
Balance at end of period at Jun. 30, 2026 $ 521,092 $ 294,243 226,849
Balance at beginning of period (in shares) at Mar. 31, 2026   18,577  
Balance at beginning of period at Mar. 31, 2026 501,046 $ 282,243 218,803
Increase (Decrease) in Stockholders' Equity [Roll Forward]      
Net Income 14,772   14,772
Dividend Reinvestment & Common Stock Purchase Plan (in shares)   4  
Dividend Reinvestment & Common Stock Purchase Plan 218 $ 218  
Restricted Stock Award - Net - Employees (in shares)   38  
Restricted Stock Award -Net-Employees 208 $ 208  
Restricted Stock Award - Board of Directors (in shares)   8  
Restricted Stock Award - Board of Directors 405 $ 405  
At-The-Market Program Common Stock Issuance (in shares)   216  
At-The-Market Program Common Stock Issuance 11,327 $ 11,327  
Common Stock Issuance Expense (158) $ (158)  
Cash Dividends on Common Stock (6,709)   (6,709)
Cash Dividends on Preferred Stock $ (17)   (17)
Balance at end of period (in shares) at Jun. 30, 2026 18,843 18,843  
Balance at end of period at Jun. 30, 2026 $ 521,092 $ 294,243 $ 226,849